hile the world continues to face ongoing challenges with HIV and tuberculosis, and many unknown and emerging threats, there is also an increasing shift in burden of disease toward noncommunicable diseases (NCDs) and mental health. At Johnson & Johnson, we are passionate about our work to save and improve people’s lives. We forge partnerships and identify new ways to pioneer human ingenuity to accelerate the development of new drug regimens, support the strengthening of healthcare systems and break down barriers to access in resource-limited settings.
Our aspiration: A world where innovations and holistic health solutions prevent, control and eliminate global disease challenges and epidemics.
Our five-year target: 175 million individuals will have benefited from Johnson & Johnson solutions that prevent, control and eliminate global diseases.